Letters to the Editor Open access

Takotsubo syndrome in association with pheochromocytoma: clinical and practical considerations

Authors

Published
26 May 2021
Section
Letters to the Editor
DOI
10.4081/monaldi.2021.1848

Abstract

In clinical practice, pathophysiology of Takotsubo syndrome (TTS) has been attributed to adrenergic discharge mostly associated with a variety of stressors. Occasionally, organic sources of adrenergic discharge (including pheochromocytoma) might also account for this phenomenon and are not considered as exclusion criteria for the diagnosis of TTS (as opposed to previous suggestions). We read with great interest the recently published article by Maffè et al. that describes a case of fatal TTS due to a ruptured pheochromocytoma in a middle-aged male. In this context, we would like to comment on this interesting case and potential implications of TTS associated with pheochromocytoma....

Keywords

References

  1. Maffè S, Dellavesa P, Paffoni P, et al. Takotsubo syndrome and pheochromocytoma: an insidious combination. Monaldi Arch Chest Dis 2021. doi: 10.4081/monaldi.2021.1711. Epub ahead of print. DOI: https://doi.org/10.4081/monaldi.2021.1711
  2. Yalta K, Yetkin E, Yalta T. Systemic inflammation in patients with Takotsubo syndrome: a review of mechanistic and clinical implications. Monaldi Arch Chest Dis 2021;91:1718. DOI: https://doi.org/10.4081/monaldi.2021.1718
  3. Yalta K, Taylan G, Yalta T, et al. Takotsubo cardiomyopathy in the setting of multiple sclerosis: a multifaceted phenomenon with important implications. Monaldi Arch Chest Dis 2020;90:1420. DOI: https://doi.org/10.4081/monaldi.2020.1420
  4. Y-Hassan S. Clinical features and outcome of pheochromocytoma-induced takotsubo syndrome: Analysis of 80 published cases. Am J Cardiol 2016;117:836-44. DOI: https://doi.org/10.1016/j.amjcard.2016.03.019

Metrics

Citations and online attention from Dimensions, Altmetric and PlumX.

PlumX Metrics

License

Copyright (c) 2021 The Author(s)

Creative Commons License

This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.

PAGEPress has chosen to apply the Creative Commons Attribution NonCommercial 4.0 International License (CC BY-NC 4.0) to all manuscripts to be published.